Total Payments
$5,896
2024 Payments
$553.89
Companies
26
Transactions
139
Medicare Patients
12,085
Medicare Billing
$8.1M
Payment Breakdown by Category
Food & Beverage$5,513 (93.5%)
Travel$334.80 (5.7%)
Other$48.80 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,513 | 135 | 93.5% |
| Travel and Lodging | $334.80 | 1 | 5.7% |
| Entertainment | $48.80 | 1 | 0.8% |
| Unspecified | $0 | 2 | 0.0% |
Payments by Type
General
$5,896
137 transactions
Ownership
$0
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $1,190 | 37 | $0 (2024) |
| Alcon Vision LLC | $967.36 | 11 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $648.60 | 16 | $0 (2023) |
| Genentech USA, Inc. | $509.60 | 21 | $0 (2024) |
| Genentech, Inc. | $357.12 | 2 | $0 (2018) |
| Allergan, Inc. | $279.36 | 5 | $0 (2021) |
| Sight Sciences, Inc. | $239.26 | 2 | $0 (2021) |
| Mallinckrodt Hospital Products Inc. | $176.57 | 3 | $0 (2023) |
| Alimera Sciences, Inc. | $174.90 | 9 | $0 (2024) |
| Dutch Ophthalmic, USA | $151.36 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $553.89 | 22 | Alcon Vision LLC ($116.09) |
| 2023 | $489.53 | 13 | Alcon Vision LLC ($145.14) |
| 2022 | $754.06 | 24 | Regeneron Healthcare Solutions, Inc. ($156.43) |
| 2021 | $1,071 | 31 | Regeneron Healthcare Solutions, Inc. ($305.88) |
| 2020 | $639.40 | 14 | Alcon Vision LLC ($292.86) |
| 2019 | $736.02 | 13 | Alcon Vision LLC ($274.95) |
| 2018 | $1,239 | 15 | Genentech, Inc. ($357.12) |
| 2017 | $414.06 | 7 | Alcon Research Ltd ($100.45) |
All Payment Transactions
139 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 11/10/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $31.42 | General |
| Category: Ophthalmology | ||||||
| 09/23/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 08/26/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Ophthalmology | ||||||
| 08/22/2024 | Alcon Vision LLC | NGENUITY (Device) | Food and Beverage | In-kind items and services | $56.94 | General |
| Category: Ophthalmology | ||||||
| 08/19/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $34.36 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/02/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Ophthalmology | ||||||
| 07/29/2024 | Biogen, Inc. | BYOOVIZ (Biological) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Ophthalmology | ||||||
| 06/24/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Ophthalmology | ||||||
| 05/30/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $34.10 | General |
| Category: Ophthalmology | ||||||
| 05/13/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $34.46 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/09/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $34.47 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/06/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 03/26/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Ophthalmology | ||||||
| 03/25/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 03/04/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: Ophthalmology | ||||||
| 03/01/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/27/2024 | Biogen, Inc. | BYOOVIZ (Biological) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Ophthalmology | ||||||
| 02/05/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Ophthalmology | ||||||
| 02/05/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: EYE CARE | ||||||
| 01/25/2024 | Halozyme Inc | HYLENEX RECOMBINANT (Biological) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: OPTHALMOLOGY | ||||||
| 01/23/2024 | Biogen, Inc. | BYOOVIZ (Biological) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Ophthalmology | ||||||
| 11/30/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $30.54 | General |
| 11/29/2023 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Ophthalmology | ||||||
| 10/19/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $126.42 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 3,265 | 24,235 | $9.8M | $2.5M |
| 2022 | 20 | 3,287 | 14,144 | $9.1M | $2.2M |
| 2021 | 19 | 3,171 | 10,940 | $8.2M | $2.1M |
| 2020 | 18 | 2,362 | 7,734 | $2.1M | $1.3M |
Total Patients
12,085
Total Services
57,053
Medicare Billing
$8.1M
Procedure Codes
76
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 227 | 2,040 | $4.6M | $1.4M | 30.7% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 38 | 12,720 | $1.2M | $369,882 | 31.3% |
| 67028 | Injection of drug into eye | Office | 2023 | 442 | 2,309 | $2.3M | $214,428 | 9.2% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 32 | 874 | $491,366 | $156,895 | 31.9% |
| 92134 | Imaging of retina | Office | 2023 | 981 | 3,155 | $317,892 | $93,818 | 29.5% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 711 | 858 | $270,660 | $76,529 | 28.3% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 274 | 1,388 | $281,993 | $75,126 | 26.6% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2023 | 16 | 182 | $88,468 | $27,865 | 31.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 196 | 283 | $63,397 | $18,106 | 28.6% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 12 | 12 | $42,210 | $10,928 | 25.9% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2023 | 11 | 11 | $38,693 | $10,319 | 26.7% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 66 | 69 | $23,835 | $7,291 | 30.6% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2023 | 11 | 17 | $37,400 | $4,391 | 11.7% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 16 | 19 | $61,098 | $3,650 | 6.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 54 | 89 | $12,503 | $3,524 | 28.2% |
| 92250 | Photography of the retina | Office | 2023 | 102 | 123 | $19,418 | $3,367 | 17.3% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 22 | 22 | $8,207 | $2,162 | 26.3% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 38 | 47 | $2,894 | $888.43 | 30.7% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 16 | 17 | $4,615 | $647.71 | 14.0% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 153 | 1,866 | $4.3M | $1.3M | 31.4% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 42 | 1,300 | $911,955 | $273,485 | 30.0% |
| 67028 | Injection of drug into eye | Office | 2022 | 438 | 2,441 | $2.4M | $222,716 | 9.1% |
| 92134 | Imaging of retina | Office | 2022 | 871 | 3,059 | $313,951 | $91,504 | 29.1% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 288 | 1,608 | $277,657 | $83,693 | 30.1% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 658 | 819 | $261,879 | $70,538 | 26.9% |
About Dr. Ryan Whitted, MD
Dr. Ryan Whitted, MD is a Ophthalmology healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2008. The National Provider Identifier (NPI) number assigned to this provider is 1326295502.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Whitted, MD has received a total of $5,896 in payments from pharmaceutical and medical device companies, with $553.89 received in 2024. These payments were reported across 139 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($5,513).
As a Medicare-enrolled provider, Whitted has provided services to 12,085 Medicare beneficiaries, totaling 57,053 services with total Medicare billing of $8.1M. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist, Ophthalmology
- Location Atlanta, GA
- Active Since 08/19/2008
- Last Updated 07/08/2019
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1326295502
Products in Payments
- EYLEA (Biological) $790.99
- Constellation (Device) $698.06
- EYLEA AFLIBERCEPT INJECTION (Biological) $462.87
- Non-Covered Product (Drug) $357.12
- BEOVU (Drug) $344.07
- Lucentis (Biological) $337.34
- OMNI(R) SURGICAL SYSTEM (US) (Device) $239.26
- OZURDEX (Drug) $202.68
- NGENUITY (Device) $195.26
- ACTHAR (Biological) $176.57
- EVA, combined machine (Device) $151.36
- TEPEZZA (Drug) $127.18
- LUMIGAN (Drug) $125.00
- Cequa (Drug) $113.12
- Vabysmo (Drug) $106.52
- BROLUCIZUMAB (Drug) $105.64
- Humira (Biological) $92.25
- ForeseeHome (Device) $91.92
- YUTIQ (Drug) $87.70
- ILUVIEN (Drug) $87.20
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Atlanta
Lawrence Woodard, M.d, M.D
Ophthalmology — Payments: $546,343
Ophthalmology $546,343
Arkadiy Yadgarov
Ophthalmology — Payments: $537,190
Ophthalmology $537,190
William Lee, Md, MD
Ophthalmology — Payments: $496,418
Ophthalmology $496,418
Stephanie Vanderveldt, Md, MD
Ophthalmology — Payments: $488,410
Ophthalmology $488,410
Dr. Gagan Sawhney, Md, MD
Ophthalmology — Payments: $419,278
Ophthalmology $419,278
Dr. Margaret Wong Gribble, Md, MD
Ophthalmology — Payments: $375,575
Ophthalmology $375,575